RANEHOLDIN2023-04-012023-06-30 RANEHOLDIN2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member RANEHOLDIN2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member RANEHOLDIN2023-04-012023-06-30in-bse-fin:OneOperatingExpenses03Member RANEHOLDIN2023-06-30 RANEHOLDIN2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member RANEHOLDIN2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 505800 RANEHOLDIN NOTLISTED Rane Holdings Limited Equity 2023-04-01 2024-03-31 2023-08-04 2023-06-29 INR Lakhs First quarter 11:30:00 12:09:00 2023-08-04 2023-08-04 Not applicable Single segment The Company holds strategic investments in subsidiaries and joint ventures (collectively called the Group), engaged primarily in manufacturing / marketing of components and providing technological services for the transportation industry, mainly the automotive sector and also provides management information technology and business development services to the Group 2023-04-01 2023-06-30 Unaudited Standalone 255400000.00 1800000.00 257200000.00 0.00 0.00 0.00 71600000.00 12900000.00 12100000.00 55900000.00 152500000.00 104700000.00 -29600000.00 75100000.00 15500000.00 -200000.00 15300000.00 0.00 59800000.00 0.00 0.00 0.00 0.00 59800000.00 -4900000.00 54900000.00 54900000.00 0.00 142778000.00 10 4.19 4.19 0.00 0.00 4.19 4.19 4. Share of profit / (loss) of jv / associate entities disclosed in the unaudited Cons. FR includes the share of exceptional item, recorded by RNSS of Rs. Nil for the qtr ended Jun 30, 23 and Jun 30, 22, Rs. 3,626 Lks for the qtr and year ended Mar 31, 23. This was incurred by RNSS towards incremental warranty claims with respect to certain specific lots of products sold by RNSS to one of its customers. RNSS has determined the amount based on technical estimates and is currently in discussions with various parties to determine and conclude on certain aspects that may impact the quantum of the final warranty liability to be borne by RNSS. Based on its assessment and pending final outcome of such discussions and negotiations, RNSS believes that the cumulative provision carried by them towards such special warranty obligations as at Jun 30, 23, is adequate. 5.Exceptional items in the above FR includes the following: a. In respect of Rt4u, the Co assessed the carrying value of its investments and considered the fair value changes thereto resulting in a reduction in the carrying value aggregating to Rs.296 Lks for the qtr ended Jun 30, 23, Rs. 292 Lks for the qtr and year ended Mar 31, 2023 being shown as an exceptional charge in the stan. FR. b.REVL incurred a provision for customer quality claims for Rs. 113 Lks for the qtr ended Jun 30, 23, Rs. 199 Lks for the qtr ended Mar 31, 23, Rs. 105 Lks for the qtr ended Jun 30, 22, and Rs. 619 Lks for the year ended Mar 31, 23 towards estimated product liability costs, in respect of certain valves supplied to an overseas customer pending finalisation. REVL has initiated insurance claim in respect of the same, which is under process. The Mgt is of the opinion that the provision carried as at Jun 30, 23 is adequate to cover the estimated net liability. Further, REVL has incurred VRS expenditure of Rs. 48 Lks for the year ended Mar 31, 23. c. RML primarily incurred provision for one time warranty related costs and VRS expenditure of Rs. 1,875 Lks for the qtr ended Jun 30, 23 and VRS expenditure of Rs. 261 Lks for the year ended Mar 31, 23. As at Mar 31, 23, on account of changes in market conditions and rising cost of capital, the Grp has assessed the recoverable amount of the net assets of LMCA the step-down subsidiary in the U.S , which represents a single CGU. Based on such assessment, the Grp has recorded an impairment charge of Rs. 904 Lks as an exceptional item in its Cons. FR during the qtr and year ended Mar 31, 2023. 6.During the qtr ended Jun 30, 23, the Co acquired 1,71,821 equity shares of Rs.10 each fully paid-up in REVL pursuant to conversion of 1,71,821 share warrants for an aggregate consideration of Rs.500 Lks (including the share warrant exercise price of Rs. 125 Lks). Pursuant to such acquisition, the shareholding of the Co in REVL stands at 58.29%. 7. During the qtr, the Co acquired 21,60,432 equity shares of Rs.10 each on rights basis and converted the 2,78,50,000 CCPS of Rs.10 each held by the Co in Rt4u into 2,78,50,000 equity shares of Rs.10/- each. Pursuant to such acquisition, the shareholding of the Co in Rt4u stands at 99.47%. 8. On May 31, 23, the BoD approved the sale of its entire investment in Rt4U for a consideration of Rs. 850 Lks in exchange for allotment of 8,62,505 equity shares in eTrans representing 11.94% stake. The sale was completed subsequent to the qtr and Rt4U ceased to be a subsidiary of the Co effective Jul 19, 2023. During the qtr, BoD and shareholders of RML approved the sale/ divestment/ pledge/ dilution/ disposal of LMCA and/ or cessation of control of RML in LMCA. This is owing to changes in market conditions and re-prioritization of investments. 9. During the qtr, ZROS commenced operations. Information system expenses 19600000.00 Other expenses 24700000.00 Professional charges 11600000.00 Re-measurement gains / (losses) on defined benefit plans, net -6800000.00 Net gain / (loss) on fair value through other comprehensive income equity instruments 400000.00 -6400000.00 -1500000.00 0.00